Study finds statins lower risk of dying from four common cancers
A study conducted for a long period of 14 years on one million people has found that statins have potential to increase survival rate in patients with the four most common types of cancer: breast, lung, prostate and bowel cancer.
The study was in form of a huge survey conducted by researchers at Aston Medical School in Birmingham. They found strong associations between high cholesterol and improved mortality among people suffering from these cancers. They said this link could exist due to use of statin drugs by patients with high cholesterol.
The study finding suggests there is need for another research to find if the statin drugs have something that works against cancer. Statins are a group of medicines that help lower the level of low-density lipoprotein or bad cholesterol in the blood. Over seven million people in the UK are believed to take the drugs every day to prevent conditions such as stroke and coronary heart disease.
As part this study, researchers examined UK hospital data from between January 2000 and March 2013 and also information from the Office for National Statistics. High cholesterol is strongly associated with obesity which further is associated with a higher risk of a number of forms of cancer.
They found that a diagnosis of high cholesterol was associated with a 22% lower risk of death within five years for patients with lung cancer. For breast cancer patients, there was a 43% lower risk of death, while for patients with prostate and bowel cancer, risk of death decreased by 47% and 30%, respectively.
Health care cost per person this year in the US is...Read More
Scientists have found a new way to understand human...Read More
Southeast is having a very good season of...Read More
NASA’s Juno spacecraft, which has started orbiting...Read More
There are vast numbers of tree species in the...Read More